Los Angeles Capital Management’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-29,470
| Closed | -$306K | – | 2452 |
|
|
2025
Q4 | $306K | Hold |
29,470
| – | – | ﹤0.01% | 1089 |
|
|
2025
Q3 | $293K | Sell |
29,470
-2,880
| -9% | -$30K | ﹤0.01% | 1140 |
|
|
2025
Q2 | $321K | Buy |
+32,350
| New | +$341K | ﹤0.01% | 1022 |
|
|
2024
Q1 | – | Sell |
-63,774
| Closed | -$892K | – | 1157 |
|
|
2023
Q4 | $892K | Sell |
63,774
-15,498
| -20% | -$215K | ﹤0.01% | 713 |
|
|
2023
Q3 | $1.17M | Buy |
79,272
+1,699
| +2% | +$23.9K | 0.01% | 589 |
|
|
2023
Q2 | $1M | Sell |
77,573
-3,907
| -5% | -$44.5K | ﹤0.01% | 655 |
|
|
2023
Q1 | $799K | Sell |
81,480
-1,229
| -1% | -$13.1K | ﹤0.01% | 726 |
|
|
2022
Q4 | $880K | Buy |
82,709
+37,878
| +84% | +$440K | ﹤0.01% | 739 |
|
|
2022
Q3 | $468K | Buy |
44,831
+28,224
| +170% | +$368K | ﹤0.01% | 945 |
|
|
2022
Q2 | $209K | Sell |
16,607
-2,211
| -12% | -$23.5K | ﹤0.01% | 1253 |
|
|
2022
Q1 | $204K | Buy |
+18,818
| New | +$229K | ﹤0.01% | 1354 |
|
|
2021
Q4 | – | Sell |
-57,885
| Closed | -$1.11M | – | 1419 |
|
|
2021
Q3 | $1.11M | Sell |
57,885
-33,460
| -37% | -$444K | 0.01% | 722 |
|
|
2021
Q2 | $900K | Sell |
91,345
-45,489
| -33% | -$414K | ﹤0.01% | 902 |
|
|
2021
Q1 | $1.34M | Buy |
136,834
+102,322
| +296% | +$844K | 0.01% | 768 |
|
|
2020
Q4 | $154K | Buy |
+34,512
| New | +$156K | ﹤0.01% | 1487 |
|
|
2018
Q3 | – | Sell |
-10,929
| Closed | -$167K | – | 1414 |
|
|
2018
Q2 | $167K | Sell |
10,929
-5,029
| -32% | -$86.9K | ﹤0.01% | 1399 |
|
|
2018
Q1 | $317K | Buy |
+15,958
| New | +$276K | ﹤0.01% | 1165 |
|
Other funds holding DVAX
Los Angeles Capital Management's DVAX Position: Q1 2026 in Review
Los Angeles Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 29,470 shares — an estimated $306K sold.
Los Angeles Capital Management first reported a position in DVAX in Q1 2018 and held it in 17 quarters. The position peaked at $1.34M in Q1 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Los Angeles Capital Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Los Angeles Capital Management sold 29,470 Dynavax Technologies shares in Q1 2026, an estimated $306K.
- Los Angeles Capital Management first reported a position in Dynavax Technologies in Q1 2018 and held it in 17 quarters.
- Los Angeles Capital Management's Dynavax Technologies position peaked at $1.34M in Q1 2021.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.